Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¸¸¼º CÇü °£¿°ÀÇ ¾à¹° Ä¡·á¿Í ¿¬°üµÈ ±¸°­ ³» »ö¼Ò ħÂøÀÇ Ä¡Çè·Ê

Oral Pigmentation Resulting from Pharmacological Treatment in Patient with Chronic Hepatitis C

´ëÇѱ¸°­³»°úÇÐȸÁö 2012³â 37±Ç 4È£ p.189 ~ 193
±è¿µ°Ç, ¾ÈÇüÁØ, ÃÖÁ¾ÈÆ, ±ÇÁ¤½Â,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿µ°Ç ( Kim Young-Gun ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
¾ÈÇüÁØ ( Ahn Hyung-Joon ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
ÃÖÁ¾ÈÆ ( Choi Jong-Hoon ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
±ÇÁ¤½Â ( Kwon Jeong-Seung ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç

Abstract

±¸°­³»ÀÇ ´Ù¹ß¼º »ö¼ÒħÂøÀº ¾Öµð½¼ÁõÈıº, Æ÷ÀÌÃ÷-¿¹°Å ÁõÈıº°ú °°Àº ¼±Ãµ¼ºÁúȯ¿¡ ÀÇÇÏ¿© À¯¹ßµÇ°Å³ª, ¾Ç¼º Èæ»öÁ¾, Èæ»ö±Ø¼¼Æ÷Á¾, ½Å°æ¼¶À¯Á¾Áõ°ú °°Àº ±¹¼ÒÀûÀÎ Áúȯ, Èí¿¬, ¸¸¼º ¿Ü»ó, ¾à¹° º¹¿ë µî¿¡ ÀÇÇؼ­ À¯¹ßµÉ ¼ö ÀÖ´Ù. ÀÌ·¯ÇÑ Áúȯ Áß ¾Ç¼ºÈæ»öÁ¾°ú °°Àº ÁúȯÀº »ý¸íÀ» À§ÇùÇÒ ¼ö ÀÖ´Â ÁúȯÀ̹ǷΠ±¸°­ ³» »ö¼Ò ħÂøÀÌ ¹ß°ßµÉ °æ¿ì Á¤È®ÇÑ Áø´ÜÀÌ ÇʼöÀûÀÌ´Ù. ÀÌ·¯ÇÑ º´¼ÒÀÇ Á¤È®ÇÑ °¨º° Áø´ÜÀ» À§Çؼ­´Â ±¸°­ ³» »ö¼Ò ħÂøÀ» À¯¹ßÇÒ ¼ö ÀÖ´Â ¿øÀο¡ ´ëÇؼ­ ¼÷ÁöÇÏ°í ÀÖ¾î¾ß Çϸç, »ó¼¼ÇÑ º´·Â ûÃë°¡ Áß¿äÇÏ´Ù. ¶ÇÇÑ, ÇÊ¿ä ½Ã Ç÷¾×°Ë»ç¸¦ ºñ·ÔÇÑ ÀÌÈ­Çа˻縦 ½ÃÇàÇϰųª »ý°ËÀ» ÅëÇÏ¿© Á¶Á÷º´¸®ÇÐÀûÀÎ ¼Ò°ßÀ» È®ÀÎÇÏ°í, ÁÖ±âÀûÀ¸·Î ȯÀÚÀÇ ÀÓ»ó ¼Ò°ß¿¡ ´ëÇÑ Æò°¡¸¦ ½ÃÇàÇÏ¿© º¯È­¸¦ È®ÀÎÇÏ¿©¾ß ÇÑ´Ù. ±× µ¿¾È ÀϹÝÀûÀ¸·Î »ö¼Ò ħÂøÀ» À¯¹ßÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ³´ø ¾à¹° ¿Ü¿¡, ¸¸¼º CÇü °£¿° ȯÀÚ¿¡¼­ Æä±×ÀÎÅÍÆä·Ð ¾ËÆÄ¿Í ¸®¹Ùºñ¸°ÀÇ º´¿ë ¿ä¹ý Áß ¹ß»ýÇÑ ±¸°­ ³» ´Ù¹ß¼º »ö¼Ò ħÂø Áõ·Ê°¡ ÀÖ¾î ¹®Çå »ó¿¡ º¸°íµÇ¾ú´ø ¸¸¼º CÇü °£¿° ȯÀÚÀÇ ¾à¹°Ä¡·á¿Í ¿¬°üµÈ ±¸°­ ³» »ö¼Ò ħÂøÀÇ Áõ·Êµé°ú ÇÔ²² °íÂûÇØ º¸°íÀÚ ÇÑ´Ù.

Oral pigmentation has numerous etiologies. It can be associated with congenital diseases and syndromes, certain acquired diseases, and systemic medications. Pigmented lesions caused by serious disease such as melanoma should be diagnosed correctly, because it would be fatal. For appropriate differential diagnosis, clinicians should know about the etiologies causing oral pigmentation and take patients history carefully. Biopsies would be necessary for histopathological findings. Close follow up for clinical symptoms are also necessary. In this case report, we presented a case of oral hyperpigmentation in Asian patient who was receiving pegylated interferon and ribavirin combination therapy for hepatitis C virus infection.

Å°¿öµå

CÇü °£¿°; »ö¼Ò ħÂø; ÀÎÅÍÆä·Ð; ¸®¹Ùºñ¸°
Hepatitis C virus; Oral hyperpigmentation; Interferon; Ribavirin

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI